Considering our flow cytometry results indicated that there was a reduction in NK cells in the peripheral blood of SARIFA-positive CRC patients, we immunostained for CD56 as a surrogate marker for NK cells/NK-like lymphocytes and CD57 as a marker for a terminally differentiated, cytotoxic NK cell subpopulation. The gene discussed is NCAM1; the disease is colorectal carcinoma.